Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. <i>Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”</i>
Antonio Bertoletti, Anthony T. Tan
Topics & Concepts
Hepatitis B virusVirologyMedicineHepatocellular carcinomaHepatitis BImmunologyInternal medicineVirusCAR-T cell therapy researchVirus-based gene therapy researchImmune Cell Function and Interaction